Universal Health Realty Income Trust: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Aug 8, 2023 and accepted by EDGAR at Aug 8, 2023, 16:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $23.8m | us-gaap:Revenues |
| Revenue | 6 months2023-01-01 to 2023-06-30 | $47.0m | us-gaap:Revenues |
| Operating income | 3 months2023-04-01 to 2023-06-30 | $7.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-06-30 | $15.2m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2023-04-01 to 2023-06-30 | $3.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-06-30 | $7.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-01 to 2023-06-30 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-06-30 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | $0.25 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-06-30 | $0.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 13,809,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-06-30 | 13,806,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-06-30 | $22.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 3 months2023-04-01 to 2023-06-30 | $10.0m | us-gaap:PaymentsOfDividends |
| Dividends paid | 6 months2023-01-01 to 2023-06-30 | $19.8m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2023-06-30 | $9.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2023-06-30 | $603.0m | us-gaap:Assets |
| Total liabilities | At period end2023-06-30 | $386.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-06-30 | $216.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-039868. Last ingested by Listed: Oct 27, 2026, 16:26 ET. Listed shows no prices and gives no investment advice.